Bardoxolone-Methyl is a semi-synthetic triterpenoid that activates the Nrf2 pathway to increase ROS scavenging and reduce the side effects of cancer treatments by bolstering the antioxidant defenses [75]. This evidence concerns the gene NFE2L2 and cancer.